At BD we engage with healthcare professionals (“HCPs”) and healthcare organizations (“HCOs”) to pursue our purpose of advancing the world of health™. BD is committed to providing clear insight about how we operate, conduct business globally, and remain transparent in the relationships we have with HCPs and HCOs.
BD holds the value that “We do what is right” and is fully committed to upholding the highest ethical standards set forth by all government regulatory bodies and all industry codes surrounding conduct engaging HCPs and HCOs.
In the United States, the Sunshine Act and various State healthcare transparency disclosure laws require that medical device and pharmaceutical manufacturers publicly report payments or transfers of value made to U.S. licensed HCPs or HCOs on an annual basis. The Sunshine Act is administered by the Center for Medicare & Medicaid Services (CMS). BD’s data regarding payments or transfers of value made to HCP’s and HCO’s is publicly available and can be found on the CMS Open Payment Database.
Further information regarding the Sunshine Act/Open Payments Program can be found in the following links: